Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (3797)	1/11/2001 1:14:25 AM
From: RJMC	Read Replies (1) \| Respond to of 5665

Thanks Gary. The 50% tumor shrinkage milestone is very intriguing. Any idea how that would work? Is this a 50% reduction in a certain percentage of the patients? I agree we'll hear about the huN901-DM1 trials beginning. I'm not sure whether that will get us out of the mode where we are tracking the biotech sector but it certainly couldn't hurt. Regardless of what happens this month or during the first quarter, overall, its going to be a great year! Bob M.